Drug recall · July 10, 2024
Dodex Injectable recall
Why: Subpotent drug: out of specification results
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India, NDC 16729-533-08, UPC Code: 031672953308
- Lots / codes
Lot# R2200834, R2200835, R2200841, R2200958, Exp 06/30/2024; R2201044 R2201045 R2201046, R2201047, R2201095, R2201142, R2201143, R2201144, Exp 07/31/2024; M2215870, M2215918, Exp 10/2024
- Quantity
- 52,998
- Company
- Accord Healthcare, Inc., Durham, NC
- Distribution
- USA Nationwide
- Initiated
- June 18, 2024 · Voluntary: Firm initiated
- Classified
- July 2, 2024
- Reported
- July 10, 2024
- Ended
- February 12, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.